Therefore we asked whether a generalized MLR model based on the large number of patients amongst the three cancer types (in total 1907 patients) studied so far could be extrapolated to accurately predict PD-L1 expression in patients with other cancer types, thereby identifying patients with a high CD274 expression that cannot be explained by TF activity. The gene discussed is TF; the disease is cancer.